Mark Benedyk Email and Phone Number
Mark Benedyk work email
- Valid
- Valid
- Valid
- Valid
Mark Benedyk personal email
Mark Benedyk phone numbers
Life sciences executive with broad experience leading and building emerging and rapid growth Biotech and Specialty Pharma companies. Experienced in multiple aspects of company formation including asset valuation and fundraising, operations, staffing, and cash flow management. Experience spanning early–stage drug discovery through life cycle management of marketed products. Particularly skilled in translating complex science and technology into a product concept with a clear and understandable value proposition that resonates with investors.Deep and broad base of operating executive experience in numerous start-ups, emerging companies and established firms including Pfizer and Elan Pharmaceuticals (now Perrigo).Active with The National Association of Corporate Directors (NACD) at both the national level and with the Southern California Chapter. Director at Accel-Rx, Pulmotect, Alafair Biosciences and BioSigID. Prior Director at The Center for Drug Development Ventures, Inc, Amarantus Biosciences (OTC: AMBS) and The Pfizer Incubator, LLC. Has served on three company compensation committees, and is available for public and private company Board roles.
-
Consulting Operating PartnerSweetwater Capital Advisors, Llc Oct 2018 - PresentSweetwater Capital is a boutique secondaries private equity firm that helps General & Limited Partners generate liquidity and rebalance private equity exposure across multiple asset types. At Sweetwater, I provide Advisory and General Partner support on direct secondary life science transactions in areas including oncology, infectious disease, inflammation, pharmacy services, and medical devices. Also provide portfolio strategic investment support for the Texas Treasury Safekeeping Trust Company client as part of administration of its $300M Enterprise Technology Fund portfolio. Board member at Treasury Safekeeping Trust Company portfolio companies Alafair Biosciences, BioSigID and Pulmotect and board observer at Shape Memory Medical.
-
DirectorAlafair Biosciences Oct 2018 - PresentAlafair Biosciences is a life sciences company specializing in the development and commercialization of biomaterials and biomedical devices to enhance internal wound healing. The company develops proprietary hydrogel film products to address post-surgical complication of unwanted soft tissue adhesions that can severely impact healing and mobility in patients undergoing tendon or nerve surgery. It also develops membrane, bilayer, and injectable gel solutions for applications in scar prevention, wound care, and tissue reconstruction. The Company was founded in 2011 and is based in Austin, Texas.
-
DirectorPulmotect, Inc. Mar 2017 - PresentHouston, Texas, UsPulmotect is a clinical stage biopharmaceutical company that develops immunotherapy products to reduce morbidity and mortality in patients at risk of severe respiratory infection.Pulmotect products utilize a platform technology that stimulates the body’s innate immune system to provide safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague).
-
Managing MemberRila Partners Llc 2011 - PresentBusiness and Corporate Development consultancy
-
AdvisorTechnology Multipliers, Llc Aug 2011 - PresentSan Diego, Us -
DirectorBiometric Signature-Id Jan 2019 - Dec 2020Lewisville, Tx, UsBiometric Signature ID is based in Dallas, Texas and is a leading developer of biometric ID verification software solutions using multi-factor authentication (MFA). Its innovative identity solution BioSig-ID authenticates individuals with a unique finger or mouse drawn password that imposters cannot replicate. Biometric Signature ID has been named to the committee developing the next generation of Identity Proving and Verification standards (IDP-V) that will be ANSI (American National Standards Institute) approved. -
Executive DirectorAmebagone, Inc. Apr 2018 - Jan 2019Madison, Wisconsin, UsAmebaGone is developing novel biocontrols for crop bacterial infections using proprietary strains of beneficial soil amoebae to replace the 50,000 pounds of antibiotics sprayed on US crops every year to treat and prevent crop bacterial infections. AmebaGone’s first program has been vetted in two field trials and the Company has secured >$3.5M in non-dilutive funding from sources including the NIH, NSF, and USDA, and is the winner of the Life Sciences category of the 2018 Wisconsin Governor’s Business Plan Competition. -
President & CeoTelephus Medical Llc Dec 2012 - Oct 2018Telephus is developing TPH 101, a monoclonal antibody designed to target antibiotic-resistant staph infections (including those caused by methicillin-resistant Staphylococcus aureus, (MRSA)) in patients undergoing two-stage septic revision surgery due to infection of artificial knee implants. Clinical candidate selection is complete for our lead program, TPH 101, and lead selection for our follow-on program, TPH 201. Both target key staphylococcal enzymes critical for MRSA virulence, colonization and replication. We have a patent estate of 17 issued patents and 17 pending applications.We see a significant role for TPH 101 not only in orthopedic septic revision procedures, but also in other clinical settings such as infective endocarditis, MRSA infections in peritoneal dialysis patients and in other implantable device infections where staphylococcal infections contribute to high morbidity and mortality.Telephus holds global, exclusive license rights to two distinct classes of neutralizing monoclonal antibodies discovered at the University of Rochester in the laboratory of Dr. Eddie Schwarz, Burton Professor of Orthopaedics and Director of the Center for Musculoskeletal Research at the University of Rochester Medical Center. The Company is based in San Diego, California.
-
Senior AdvisorSweetwater Capital Partners Jan 2018 - Sep 2018Encinitas, Ca, UsAssisting in portfolio strategy and Advisory Board development for Sweetwater's life sciences portfolio companies. Advising Sweetwater principals on client communications to build on existing General Partner services offerings to institutional clients. -
DirectorCenter For Drug Research And Development Ventures, Inc. Jan 2011 - Jan 2016Member of the Board of DirectorsCompensation Committee 2012-2014
-
Member, Translational Medicine Advisory BoardCns Regenerative Medicine Foundation Sep 2010 - Sep 2015Foundation focused on translational medicine for the development of regenerative medical therapies of the central nervous system.
-
DirectorAmarantus Bioscience Mar 2013 - Sep 2014Sunnyvale, California, UsMember of the Board of DirectorsCompensation Committee 2013-present -
AdvisorAmarantus Biosciences Jan 2011 - Sep 2014
-
Strategic AdvisorKempharm, Inc. Jan 2011 - Jan 2014Celebration, Fl, Us -
Head, The Pfizer Incubator LlcPfizer 2008 - Jan 2011New York, New York, Us -
Vice President, Business DevelopmentAscenta Therapeutics 2005 - 2007
-
Vice President, Business DevelopmentOptimer Biotechnology, Inc. 2003 - 2005Us -
Senior Director, Business DevelopmentOptimer Biotechnology, Inc. 2003 - 2005Us
-
Senior Director, Business DevelopmentVertex Pharmaceuticals 2000 - 2002Boston, Ma, Us(previously Aurora Biosciences) -
Director, Business DevelopmentElan Pharmaceuticals 1996 - 2000Dublin 2, Ie
Mark Benedyk Skills
Mark Benedyk Education Details
-
The Rockefeller UniversityGenetics And Developmental Biology -
University Of MichiganMicrobiology And Botany (Double Major)
-
Highland Park High School
Frequently Asked Questions about Mark Benedyk
What company does Mark Benedyk work for?
Mark Benedyk works for Pulmotect, Inc.
What is Mark Benedyk's role at the current company?
Mark Benedyk's current role is Consulting Operating Partner at Sweetwater Capital Advisors.
What is Mark Benedyk's email address?
Mark Benedyk's email address is mb****@****cal.com
What is Mark Benedyk's direct phone number?
Mark Benedyk's direct phone number is +185835*****
What schools did Mark Benedyk attend?
Mark Benedyk attended The Rockefeller University, University Of Michigan, Highland Park High School.
What are some of Mark Benedyk's interests?
Mark Benedyk has interest in Civil Rights And Social Action, Children, Arts And Culture.
What skills is Mark Benedyk known for?
Mark Benedyk has skills like Pharmaceutical Industry, Commercialization, Technology Transfer, Biotechnology, Medical Devices, Lifesciences, Life Sciences, Drug Development, Drug Discovery, Biopharmaceuticals, Start Ups, Strategy.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial